RYTM icon

Rhythm Pharmaceuticals
RYTM

Overview Fund Activity

203 hedge funds and large institutions have $3.63B invested in Rhythm Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 65 increasing their positions, 53 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+28
Holders Change %
+16%
% of All Funds
2.7%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.15%
New
53
Increased
65
Reduced
53
Closed
24
Calls
$26.8M
Puts
$1.76M
Net Calls
+$25M
Net Calls Change
-$16.2M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$68.3M
2
Marshall Wace
2
Marshall Wace
United Kingdom
$38.8M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$14.8M
4
UBS Group
4
UBS Group
Switzerland
$14.2M
5
SC
5
Stempoint Capital
New York
$11.6M

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$101M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$0
3
Primecap Management
3
Primecap Management
California
$368M
4
CC
4
Commodore Capital
New York
$0
5
FLSM
5
Frazier Life Sciences Management
California
$105M
Name Holding Trade Value Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$24.6M +$357K +6,384 +1%
O
27
OrbiMed
New York
$22.4M -$2.01M -35,900 -8%
CAM
28
Cormorant Asset Management
Massachusetts
$22.4M – – –
SI
29
Sofinnova Investments
California
$22.2M +$6.76M +120,750 +44%
Voloridge Investment Management
30
Voloridge Investment Management
Florida
$21.3M +$1.52M +27,214 +8%
Pictet Asset Management
31
Pictet Asset Management
Switzerland
$21M +$2.58M +46,010 +14%
CS
32
Candriam SCA
Luxembourg
$18.6M -$3.53M -62,985 -16%
Invesco
33
Invesco
Georgia
$17M +$2.15M +38,429 +15%
SCM
34
Silverarc Capital Management
Massachusetts
$15.3M +$1.03M +18,318 +7%
Franklin Resources
35
Franklin Resources
California
$15M +$492K +8,789 +3%
JPMorgan Chase & Co
36
JPMorgan Chase & Co
New York
$14.8M +$10.2M +182,993 +224%
UBS Group
37
UBS Group
Switzerland
$14.2M +$9.94M +177,630 +232%
UBS AM
38
UBS AM
Illinois
$12.2M -$382K -6,829 -3%
SC
39
Stempoint Capital
New York
$11.6M +$9.33M +166,748 +404%
Norges Bank
40
Norges Bank
Norway
$11.5M +$11.5M +205,649 New
SB
41
Samsara BioCapital
California
$9.66M – – –
Lord, Abbett & Co
42
Lord, Abbett & Co
New Jersey
$8.99M +$3.25M +58,005 +57%
IHAM
43
Integral Health Asset Management
New York
$8.4M +$8.4M +150,000 New
Bank of New York Mellon
44
Bank of New York Mellon
New York
$8.3M -$38.1K -680 -0.5%
Nuveen Asset Management
45
Nuveen Asset Management
Illinois
$8.22M -$54.4K -972 -0.7%
Walleye Capital
46
Walleye Capital
New York
$8.08M +$8.08M +144,342 New
Balyasny Asset Management
47
Balyasny Asset Management
Illinois
$7.75M +$7.75M +138,363 New
Barclays
48
Barclays
United Kingdom
$7.58M +$1.62M +29,000 +27%
First Trust Advisors
49
First Trust Advisors
Illinois
$6.62M +$2.66M +47,575 +67%
Fidelity Investments
50
Fidelity Investments
Massachusetts
$6.33M +$3.52M +62,814 +125%
1
2
3 4 5